Guardian's Generic Potassium Chloride Receives Approval in the U.S.
Guardian Drug`s Generic Loperamide HCl;Simethicone Receives Approval in US
Guardian Drug's Generic Ibuprofen Receives Approval in US
MUMBAI: The TapariaBSE 4.99 % family, who had sold Famycare, the female healthcare business to drug maker Mylan for Rs 4600 crore last year, have picked a majority stake in Guardian Lifecare, India's third largest pharmacy chain after Apollo and Medplus. The deal, under discussions for the past few months, is valued at around Rs 55 crore, a source aware of the development told ET.